Natig Ramazanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natig Ramazanov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Klimenko
Pirogov Russian National Research Medical University (Pirogov Medical University); «Kommunarka» Moscow Multidisciplinary Clinical Centre
1 shared publication - Daria Strelkova
Department of Hospital Therapy #2, I.M. Sechenov First Moscow State Medical University, Moscow, Russia, mma.ru
1 shared publication - Dmitrii V. Cheboksarov
Federal Research Clinical Center of Intensive Care and Rehabilitology
1 shared publication - Nataliia Ananicheva
Regional Vascular Center, City Clinical Hospital named after S. S. Yudin, Moscow, Russia
1 shared publication - Svetlana Aleksandrovna Rachina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - Svetlana B. Yatsyshina
Central Research Institute of Epidemiology
1 shared publication
Latest Publications
- Open Access
- 1 December 2022
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 54 (4) , 792-796
Co-Infection in COVID-19 Pneumonia: Discussion Continues
Sixty-six patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 and pneumonia on chest computer tomography were prospectively recruited. A combined respiratory swab for polymerase chain reaction (PCR), urine sample for pneumococcal and Legionella antigen, and sputum or endotracheal aspirate were collected. Urinary antigen and blood culture tests were negative in all cases as well as the PCR tests for other respiratory viruses and atypical bacterial pathogens. In total, 5 patients (7.5%) had co-infection. By PCR a high prevalence of colonization with bacterial pathogens was found. In conclusion, co -infection is rare in coronavirus disease 2019 patients, and additional examination to identify other pathogens should be performed only in selected cases.
- 1 December 2022
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 54 (4) , 792-796
Open AccessCo-Infection in COVID-19 Pneumonia: Discussion Continues
Sixty-six patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 and pneumonia on chest computer tomography were prospectively recruited. A combined respiratory swab for polymerase chain reaction (PCR), urine sample for pneumococcal and Legionella antigen, and sputum or endotracheal aspirate were collected. Urinary antigen and blood culture tests were negative in all cases as well as the PCR tests for other respiratory viruses and atypical bacterial pathogens. In total, 5 patients (7.5%) had co-infection. By PCR a high prevalence of colonization with bacterial pathogens was found. In conclusion, co -infection is rare in coronavirus disease 2019 patients, and additional examination to identify other pathogens should be performed only in selected cases.